The first described patients with MICU1 mutations exhibit a severe, complex neurological condition accompanied by muscular dystrophy and congenital myopathy, clearly associated with mitochondrial dysfunction (Logan et al., 2014), whereas a later study reported MICU1 patients with a relatively mild fatigue syndrome (Lewis-Smith et al., 2016). Here, MICU1 is linked to congenital myopathy.